Prime Medicine, Inc. (PRME)
3.55
-0.02
(-0.56%)
USD |
NASDAQ |
Sep 02, 10:42
Prime Medicine Research and Development Expense (Annual) : 160.64M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 160.64M |
| December 31, 2024 | 155.29M |
| December 31, 2023 | 147.90M |
| December 31, 2022 | 86.72M |
| Date | Value |
|---|---|
| December 31, 2021 | 70.55M |
| December 31, 2020 | 2.98M |
| December 31, 2019 | 0.92M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Beam Therapeutics, Inc. | 409.62M |
| Twist Bioscience Corp. | 80.28M |
| Sana Biotechnology, Inc. | 133.91M |
| Intellia Therapeutics, Inc. | 379.09M |
| Revolution Medicines, Inc. | 978.68M |